Skip to content
OpenCapital
Get started

Bausch Health Companies BHC International — SG&A

Other segment segments

Bausch + Lomb
$439M-1.8%
Salix
$105M-5.4%
Diversified
$43M-4.4%
Solta Medical
$35M+25.0%

Similar metrics at other companies

Avis Budget Group logo
CARInternational — SG&A
$101M+16.1%
MSA
MSAInternational — SG&A
$37.42M+18.1%
Signet Jewelers logo
SIGInternational segment — Selling, General and Administrative Expense
$29.9M+13.7%
Equifax logo
EFXInternational — Selling, general and administrative expenses
$110.5M+14.0%
Tyson Foods logo
TSNInternational — Segment Selling, General and Administrative
$29M+11.5%
Hormel Foods logo
HRLInternational — Selling, General, and Administrative
$23.69M+2.2%

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$1.79B-15.9%
Enterprise value$21.24B-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%—
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%—
Debt / equity45.2×—
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's international — sg&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch Health Companies's international — SG&A?
Bausch Health Companies (BHC) reported international — SG&A of $63M in Q1 2026.
How has Bausch Health Companies's international — SG&A changed year-over-year?
Bausch Health Companies's international — SG&A increased by 21.2% year-over-year, from $52M to $63M.
What is the long-term trend for Bausch Health Companies's international — SG&A?
Over 3 years (2022 to 2025), Bausch Health Companies's international — SG&A has grown at a 9.2% compound annual growth rate (CAGR), from $181M to $236M.
What does international — SG&A mean?
Includes all non-production costs associated with operating the international segment, such as marketing, sales force expenses, and administrative overhead. This metric measures the operational efficiency of the segment's commercial infrastructure. Monitoring this helps evaluate how effectively the company manages its overhead relative to revenue growth.